1Holman RC, Cures AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics, 2003, 112:495-501.
2Shulman ST, Melish M, lnoue O, et al. Immunoglobulin allotypic markers in Kawasaki disease. J Pediatr,1993, 122: 84-86.
3Burns JC, Shimizu C, Shike H, et al. Candidate genes for susceptibility to Kawasaki Disease: analysis of preferentially transmitted alleles inpatient/parent triads. Pediatr Res, 2003,53:325A
4Leung DY, Meissner HC, Fulton DR, et al. Toxic shock syndrome toxin-secreting staphylococcus aureus in Kawasaki syndrome. Lancet, 1993,342: 1385-1388.
5Leung DY, Meissner HC, Shulman ST, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.J Pediatr, 2002,140:742 -746.
6Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med, 1991, 324: 1633-1639.
7Hirao J, Hibi S, Andoh T, et al. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol, 1997,112: 152-156.
8Lin CY, Lin CC, Hwang B, et al. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr, 1992, 121 : 924-926.
9Amano S, Hazama F, Kubagawa H, et al. General pathology of Kawasaki disease. Acta Pathol Jpn, 1980, 30: 681-694.
10Freeman AF, Crawford SE, Finn LS, et al. Inflammatory pulmonary nodules in Kawasaki disease. Pediatr Pulmonol, 2003, 36: 102-106.
